Bio Spec Overview
Ignite Creation Date:
2025-12-25 @ 12:12 AM
Last Modification Date:
2025-12-25 @ 12:12 AM
Retention:
SAMPLES_WITH_DNA
Description:
For the development of the new biomarkers using the technique of Mass-spectrometry, a blood sample of maximal 7,5 ml blood will be taken from the patient via using a dry blood spot filter card. To proof the correct diagnosis a Tyrosinemia type 1, in those patients where up to the enrollment in the study no genetic testing has been done, sequencing of a Tyrosinemia type 1 will be done.
The analyses will be done at:
Centogene AG Am Strande 7 18055 Rostock Germany
The analyses will be done at:
Centogene AG Am Strande 7 18055 Rostock Germany
Section:
For the development of the new biomarkers using the technique of Mass-spectrometry, a blood sample of maximal 7,5 ml blood will be taken from the patient via using a dry blood spot filter card. To proof the correct diagnosis a Tyrosinemia type 1, in those patients where up to the enrollment in the study no genetic testing has been done, sequencing of a Tyrosinemia type 1 will be done.
The analyses will be done at:
Centogene AG Am Strande 7 18055 Rostock Germany